Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders

The postsynaptic density (PSD) contains a collection of scaffold proteins used for assembling synaptic signaling complexes. However, it is not known how the core-scaffold machinery associates in protein-interaction networks or how proteins encoded by genes involved in complex brain disorders are distributed through spatiotemporal protein complexes. Here using immunopurification, proteomics and bioinformatics, we isolated 2,876 proteins across 41 in vivo interactomes and determined their protein domain composition, correlation to gene expression levels and developmental integration to the PSD. We defined clusters for enrichment of schizophrenia, autism spectrum disorders, developmental delay and intellectual disability risk factors at embryonic day 14 and adult PSD in mice. Mutations in highly connected nodes alter protein–protein interactions modulating macromolecular complexes enriched in disease risk candidates. These results were integrated into a software platform, Synaptic Protein/Pathways Resource (SyPPRes), enabling the prioritization of disease risk factors and their placement within synaptic protein interaction networks.

[1]  P. Worley,et al.  Shank, a Novel Family of Postsynaptic Density Proteins that Binds to the NMDA Receptor/PSD-95/GKAP Complex and Cortactin , 1999, Neuron.

[2]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[3]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[4]  Stephan J Sanders,et al.  Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples , 2016, Nature Genetics.

[5]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[6]  S. Grant.  Synaptopathies: diseases of the synaptome , 2012, Current Opinion in Neurobiology.

[7]  Giulio Genovese,et al.  Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia , 2016, Nature Neuroscience.

[8]  Pat Levitt,et al.  The conundrums of understanding genetic risks for autism spectrum disorders , 2011, Nature Neuroscience.

[9]  L. Saksida,et al.  TNiK Is Required for Postsynaptic and Nuclear Signaling Pathways and Cognitive Function , 2012, The Journal of Neuroscience.

[10]  M. Rieder,et al.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.

[11]  M. Sheng,et al.  GKAP, a Novel Synaptic Protein That Interacts with the Guanylate Kinase-like Domain of the PSD-95/SAP90 Family of Channel Clustering Molecules , 1997, The Journal of cell biology.

[12]  Ben Lehner,et al.  Tissue specificity and the human protein interaction network , 2009, Molecular systems biology.

[13]  P. Levitt,et al.  Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse , 2016, Biological Psychiatry.

[14]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[15]  T. Pawson,et al.  Cell Signaling in Space and Time: Where Proteins Come Together and When They’re Apart , 2009, Science.

[16]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[17]  S. Grant,et al.  Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins , 2009, Molecular systems biology.

[18]  Yves Moreau,et al.  Concordance of gene expression in human protein complexes reveals tissue specificity and pathology , 2013, Nucleic acids research.

[19]  S. Grant,et al.  Proteomic analysis of NMDA receptor–adhesion protein signaling complexes , 2000, Nature Neuroscience.

[20]  Hui Yang,et al.  Phenolyzer: phenotype-based prioritization of candidate genes for human diseases , 2015, Nature Methods.

[21]  G. Kirov,et al.  Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. , 2009, Human molecular genetics.

[22]  Guoping Feng,et al.  Cellular and synaptic network defects in autism , 2012, Current Opinion in Neurobiology.

[23]  E. Koonin,et al.  Evolution of protein domain promiscuity in eukaryotes. , 2008, Genome research.

[24]  H. Ropers,et al.  Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes , 2010, Nature Genetics.

[25]  Iain D G Campuzano,et al.  Proteomic Analysis of in Vivo Phosphorylated Synaptic Proteins* , 2005, Journal of Biological Chemistry.

[26]  T. O'Dell,et al.  Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome , 2016, Science Signaling.

[27]  T. Reese,et al.  Affinity purification of PSD‐95‐containing postsynaptic complexes , 2003, Journal of neurochemistry.

[28]  P. Seeburg,et al.  Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. , 1995, Science.

[29]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[30]  Peer Bork,et al.  SMART: recent updates, new developments and status in 2015 , 2014, Nucleic Acids Res..

[31]  S. Eddy,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[32]  S. Swamy,et al.  Neurotransmitters Drive Combinatorial Multistate Postsynaptic Density Networks , 2009, Science Signaling.

[33]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[34]  S. E. Stewart,et al.  Genome-Wide Association Study in Obsessive-Compulsive Disorder: Results from the OCGAS , 2014, Molecular Psychiatry.

[35]  S. Grant,et al.  The SH3 domain of postsynaptic density 95 mediates inflammatory pain through phosphatidylinositol-3-kinase recruitment , 2010, EMBO reports.

[36]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[37]  Peter Holmans,et al.  De novo CNVs in bipolar affective disorder and schizophrenia , 2014, Human molecular genetics.

[38]  S. Grant,et al.  Characterization of the proteome, diseases and evolution of the human postsynaptic density , 2011, Nature Neuroscience.

[39]  Michael K. Coleman,et al.  Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. , 2006, Journal of proteome research.

[40]  Susanne Walitza,et al.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder , 2011, Nature Genetics.

[41]  M. Sheng,et al.  The postsynaptic organization of synapses. , 2011, Cold Spring Harbor perspectives in biology.

[42]  S. Grant,et al.  Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome , 2006, Journal of neurochemistry.

[43]  P. Billuart,et al.  Emerging major synaptic signaling pathways involved in intellectual disability , 2012, Molecular Psychiatry.

[44]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[45]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[46]  L. Castagnoli,et al.  mentha: a resource for browsing integrated protein-interaction networks , 2013, Nature Methods.

[47]  Linnaea E. Ostroff,et al.  CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation , 2013, Neuron.

[48]  Trey Ideker,et al.  Genotype to phenotype via network analysis. , 2013, Current opinion in genetics & development.

[49]  J. Ainge,et al.  Synapse-Associated Protein 102/dlgh3 Couples the NMDA Receptor to Specific Plasticity Pathways and Learning Strategies , 2007, The Journal of Neuroscience.

[50]  Tony Pawson,et al.  Eukaryotic Protein Domains as Functional Units of Cellular Evolution , 2009, Science Signaling.

[51]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[52]  David Warde-Farley,et al.  Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.

[53]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .